Q4 2024
Released Feb 19, 2025, after the close
10-K filed Feb 19, 2025, 50 days after period end · 0000950170-25-023301
Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net Income-$2.81M-$2.81M derivedN/M vs Q4 2023N/M vs Q3 2024
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$3,183,714N/M
Operating Cash Flowderived-$1,931,732N/M
Free Cash Flowderived-$1,931,730N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022 | Q4 2021 |
|---|---|---|---|---|
| Net Income | -$2.81M | -$2.06M | -$2.92M | -$3.39M |
| EPS Diluted | — | — | -$0.06 | -$0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medicinova Inc · CIK 1226616 · Engraved from SEC EDGAR